TiGenix and Takeda announce Alofisel (darvadstrocel) receives approval to treat complex perianal fistulas in Crohn’s disease in Europe Life Science Investing
Amicus Therapeutics Announces Approval of Galafold® (Migalastat) for Fabry Disease in Japan Pharmaceutical Investing
Portola Pharmaceuticals Receives and Plans to Appeal Negative CHMP Opinion Regarding Marketing Authorization for Betrixaban in the European Union Pharmaceutical Investing
CURE Pharmaceutical Announces Closing of $1 Million Bridge Financing and Prepares to Uplist to NASDAQ Pharmaceutical Investing
Vericel Reports Publication from the Phase 3 SUMMIT Extension Study Demonstrating Sustained Clinical Benefit Genetics Investing
ARCA biopharma Announces Fiscal Year 2017 Financial Results and Provides Corporate Update Biotech Investing
Progenics Pharmaceuticals Announces Three-Month Extension of PDUFA Date for AZEDRA Pharmaceutical Investing
La Jolla Pharmaceutical Announces Launch of GIAPREZA™ (angiotensin II) in the United States Biotech Investing
InMed Provides Update on BayMedica Operations and Strengthens Focus on Pharmaceutical Development Pipeline
